nach oben

Pediatric Nephrology

Erschienen in:

01.11.2015 | Educational Review

Evidence-based guidelines for the management of hypertension in children with chronic kidney disease

verfasst von: Janis M. Dionne

Erschienen in: Pediatric Nephrology | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Hypertension is common in children with chronic kidney disease and early evidence suggests that it is a modifiable risk factor for renal and cardiovascular outcomes. Recommendations for blood pressure management in children with chronic kidney disease can be found in various clinical practice guidelines including the 4th Task Force Report, the European Society of Hypertension pediatric recommendations, and the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) and Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for the management of blood pressure in chronic kidney disease. Unfortunately, as pediatric trial evidence is limited, there are discrepancies in the recommendations that may lead to inconsistent clinical care and practice variation. This article reviews the strength of evidence behind each of the clinical practice guideline recommendations regarding blood pressure assessment, treatment targets, and first-line antihypertensive medications. The benefits and cautions of use of clinical practice guidelines are described with emphasis on the importance of reading beyond the summary statements.

Nur mit Berechtigung zugänglich

Mitsnefes M, Ho P, McEnery P (2003) Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). J Am Soc Nephrol 14:2618–2622CrossRefPubMed

Flynn J, Mitsnefes M, Pierce C, Cole S, Parekh R, Furth S, Warady B (2008) Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children Study. Hypertension 52:1–7CrossRef

Wingen A, Fabian-Bach C, Schaefer F, Mehls O, for the European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood (1997) Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. Lancet 349:1117–1123CrossRefPubMed

The ESCAPE Trial Group (2009) Strict blood-pressure control and progression of renal failure in children. N Engl J Med 361:1639–1650CrossRef

Mitsnefes M, Kimball T, Kartal J, Witt S, Glascock B, Khoury P, Daniels S (2006) Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J Pediatr 149:671–675CrossRefPubMed

Kupferman J, Friedman A, Cox C, Flynn J, Furth S, Warady B, Mitsnefes M (2014) BP control and left ventricular hypertrophy regression in children with CKD. J Am Soc Nephrol 25:167–174PubMedCentralCrossRefPubMed

Brady T, Schneider M, Flynn J, Cox C, Samuels J, Saland J, White C, Furth S, Warady B, Mitsnefes M (2012) Carotid intima-media thickness in children with CKD: results from the CKiD study. Clin J Am Soc Nephrol 7:1930–1937PubMedCentralCrossRefPubMed

Litwin M, Wuhl E, Jourdan C, Niemirska A, Schenk J, Jobs K, Grenda R, Wawer Z, Rajszys P, Mehls O, Schaefer F (2008) Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. Nephrol Dial Transplant 23:2552–2557CrossRefPubMed

Matteucci M, Chinali M, Rinelli G, Wuhl E, Zurowska A, Charbit M, Pongiglione G, Schaefer F (2013) Change in cardiac geometry and function in CKD children during strict BP control: a randomized study. Clin J Am Soc Nephrol 8:203–210PubMedCentralCrossRefPubMed

10.

Greenfield S, Steinberg E, for the Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice Guidelines (2011) Clinical practice guidelines we can trust: Report Brief. Available at www.iom.edu/cpgstandards

11.

Institute of Medicine of the National Academies (2011) Clinical practice guidelines we can trust: Standards for developing trustworthy clinical practice guidelines (CPGs). Available at www.iom.edu/cpgstandards

12.

National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRef

13.

Lurbe E, Cifkova R, Cruickshank J, Dillon M, Ferreira I, Invitti C, Kuznetsova T, Laurent S, Mancia G, Morales-Olivas F, Rascher W, Redon J, Schaefer F, Seeman T, Stergiou G, Wuhl E, Zanchetti A (2009) Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 27:1719–1742CrossRefPubMed

14.

National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents (1996) Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 98:649–658

15.

National Kidney Foundation (2004) K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43:S1–S290

16.

Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group (2012) KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl 2:337–414CrossRef

17.

Lingens N, Freund M, Seeman T, Witte K, Lemmer B, Scharer K (1997) Circadian blood pressure changes in untreated children with kidney disease and conserved renal function. Acta Paediatr 86:719–723CrossRefPubMed

18.

Mitsnefes M, Kimball T, Daniels S (2003) Office and ambulatory blood pressure elevation in children with chronic renal failure. Pediatr Nephrol 18:145–149PubMed

19.

Dionne J, Turik M, Hurley R (2008) Blood pressure abnormalities in children with chronic kidney disease. Blood Press Monit 13:205–209CrossRefPubMed

20.

Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, Kimball T, Furth S, Warady G, for the CKiD Study Group (2010) Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol 21:137–144PubMedCentralCrossRefPubMed

21.

Samuels J, Ng D, Flynn J, Mitsnefes M, Poffenbarger T, Warady B, Furth S, for the Chronic Kidney Disease in Children Study Group (2012) Ambulatory blood pressure patterns in children with chronic kidney disease. Hypertension 60:43–50PubMedCentralCrossRefPubMed

22.

Lurbe E, Redon J (2002) Reproducibility and validity of ambulatory blood pressure monitoring in children. Am J Hypertens 15:69S–73SCrossRefPubMed

23.

Gimpel C, Wuhl E, Arbeiter K, Drozdz D, Trivelli A, Charbit M, Gellermann J, Dusek J, Jankauskiene A, Emre S, Schaefer F, for ESCAPE Trial Group (2009) Superior consistency of ambulatory blood pressure monitoring in children: implications for clinical trials. J Hypertens 27:1568–1574CrossRefPubMed

24.

Sorof J, Cardwell G, Franco K, Portman R (2002) Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension 39:903–908CrossRefPubMed

25.

National Heart, Lung, and Blood Institute, Task Force on Blood Pressure Control in Children (1987) Report of the Second Task Force on Blood Pressure Control in Children. Pediatrics 79:1–25

26.

Wuhl E, Witte K, Soergel M, Mehls O, Schaefer F, German Working Group on Pediatric Hypertension (2007) Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 20:1995–2007CrossRef

27.

Kavey R, Allada V, Daniels S, Hayman L, McCrindle B, Newburger J, Parekh R, Steinberger J (2006) Cardiovascular risk reduction in high-risk pediatric patients. Circulation 114:2710–2738CrossRefPubMed

28.

Furth S, Flynn J, Pierce C, Mitsnefes M, Wong C, Saland J, Moxey-Mims M, Abraham A, Warady B (2010) Lower systolic BP associated with slower CKD progression in the CKiD study. J Am Soc Nephrol 21:551ACrossRef

29.

Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo J, Jones D, Materson B, Oparil S, Wright J, Roccella E (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 289:2560–2572CrossRefPubMed

30.

Renal Association Standards and Audit Subcommittee (2002) Treatment of adults and children with renal failure: standard and audit measures, 3rd edn. Royal College of Physicians of London and the Renal Association, London. Available at www.renal.org/guidelines

31.

Sinaiko A (1996) Hypertension in children. N Engl J Med 335:1968–1973CrossRefPubMed

32.

Franscini L, Von Vigier R, Pfister R, Casaulta-Aebischer C, Fossali E, Bianchetti M (2002) Effectiveness and safety of the angiotensin II antagonist irbesartan in children with chronic kidney diseases. Am J Hypertens 15:1057–1063CrossRefPubMed

33.

Cook J, Daneman D, Spino M, Sochett E, Perlman K, Balfe J (1990) Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus. J Pediatr 117:39–45CrossRefPubMed

34.

Trachtman H, Gauthier B (1988) Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal disease. J Pediatr 112:295–298CrossRefPubMed

35.

Yuksel H, Darcan S, Kabasakal C, Cura A, Mir S, Mavi E (1998) Effect of enalapril on proteinuria, phosphaturia, and calciuria in insulin-dependent diabetes. Pediatr Nephrol 12:648–650CrossRefPubMed

36.

Sinaiko A, Kashtan C, Mirkin B (1986) Antihypertensive drug therapy with captopril in children and adolescents. Clin Exp Hypertens 8:829–839

37.

Tack E, Perlman J (1988) Renal failure in sick hypertensive premature infants receiving captopril therapy. J Pediatr 112:805–810CrossRefPubMed

38.

Pryde P, Sedman A, Nugent C, Barr M Jr (1993) Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 3:1575–1582PubMed

39.

Seeman T, Dusek J, Vondrak K, Flogelova H, Geier P, Janda J (2004) Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases. Am J Hypertens 17:415–420CrossRefPubMed

40.

Ellis D, Vats A, Moritz M, Reitz S, Grosso M, Janosky J (2003) Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria. J Pediatr 143:89–97CrossRefPubMed

41.

Simonetti G, Rizzi M, Donadini R, Bianchetti M (2007) Effects of antihypertensive drugs on blood pressure and proteinuria in childhood. J Hypertens 25:2370–2376CrossRefPubMed

42.

Gartenmann A, Fossali E, von Vigier R, Simonetti G, Schmidtko J, Edefonti A, Bianchetti M (2003) Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood. Kidney Int 64:1450–1454CrossRefPubMed

43.

The ONTARGET Investigators (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358:1547–1559CrossRef

44.

Wong C, Pierce C, Cole S, Warady B, Mak R, Benador N, Kaskel F, Furth S, Schwartz G (2009) Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the Chronic Kidney Disease in Children study. Clin J Am Soc Nephrol 4:812–819PubMedCentralCrossRefPubMed

45.

Ardissino G, Vigano S, Testa S, Dacco V, Paglialonga F, Leoni A, Belingheri M, Avolio L, Ciofani A, Claris-Appiani A, Cusi D, Edefonti A, Ammenti A, Cecconi M, Fede C, Ghio L, Manna A, Maringhini S, Papalia T, Pela I, Pisanello L, Ratsch I (2007) No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy—report from the ItalKid Project database. Nephrol Dial Transplant 22:2525–2530CrossRefPubMed

46.

White C, Macpherson C, Hurley R, Matsell D (2003) Antiproteinuric effects of enalapril and losartan: a pilot study. Pediatr Nephrol 18:1038–1043CrossRefPubMed

47.

Webb N, Shahinfar S, Wells T, Massaad R, Gleim G, Santoro E, Sisk C, Lam C (2012) Losartan and enalapril are comparable in reducing proteinuria in children. Kidney Int 82:819–826CrossRefPubMed

48.

Seeman T, Pohl M, Misselwitz J, John U (2009) Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with angiotensin-converting enzyme inhibitors. Kidney Blood Press Res 32:440–444CrossRefPubMed

49.

Lubrano R, Soscia F, Elli M, Ventriglia F, Raggi C, Travasso E, Scateni S, Di Maio V, Versacci P, Masciangelo R, Romero S (2006) Renal and cardiovascular effects of angiotensin-converting enzyme inhibitor plus angiotensin II receptor antagonist therapy in children with proteinuria. Pediatrics 118:e833–e838CrossRefPubMed

50.

Moyer VA (2013) Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force Recommendation Statement. Pediatrics 132:907–914CrossRefPubMed

51.

Shaughnessy A (2013) USPSTF: insufficient evidence to screen children and adolescents for hypertension. Daily POEMs. Wiley, New York. Available at www.essentialevidenceplus.com

52.

Kavey R, Simons-Morton D, Jesus J (2011) Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 128:S1–S44CrossRef

53.

Brady T, Redwine K, Flynn J, for the American Society of Pediatric Nephrology (2014) Screening blood pressure measurement in children: are we saving lives? Pediatr Nephrol 29:947–950CrossRefPubMed

54.

Daniels S, Gidding S (2013) Blood pressure screening in children and adolescents: is the glass half empty or more than half full? JAMA Pediatr 167:302–304CrossRefPubMed

55.

Yip G, Li A, So H, Choi K, Leung L, Fong N, Lee K, Li S, Wong S, Sung R (2014) Oscillometric 24-h ambulatory blood pressure reference values in Hong Kong Chinese children and adolescents. J Hypertens 32:606–619CrossRefPubMed

Titel: Evidence-based guidelines for the management of hypertension in children with chronic kidney disease
verfasst von: Janis M. Dionne
Publikationsdatum: 01.11.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Pediatric Nephrology / Ausgabe 11/2015
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-015-3077-7

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Evidence-based guidelines for the management of hypertension in children with chronic kidney disease

Abstract

Neu im Fachgebiet Pädiatrie

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Update Pädiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2015

Risk of persistent steroid dependency after switching from cyclosporine to mycophenolate mofetil in children with idiopathic nephrotic syndrome

Clinical efficacy and pharmacokinetics of tacrolimus in children with steroid-resistant nephrotic syndrome

Severe neutropenia in children after renal transplantation: incidence, course, and treatment with granulocyte colony-stimulating factor

Adiponectin in children and young adults with focal segmental glomerulosclerosis

Acute focal bacterial nephritis, pyonephrosis and renal abscess in children

Fibroblast growth factor 23 and acute kidney injury

Neu im Fachgebiet Pädiatrie

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Update Pädiatrie